These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7323040)

  • 21. [Blood coagulation in myocardial infarct and changes in coagulation factors during anticoagulant treatment].
    Maimunkov K; Tsekov M; Delibasheva A
    Vutr Boles; 1971; 10(5):44-51. PubMed ID: 5156217
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reparative processes in cardiac muscle following exposure to hyperbaric oxygenation].
    Makhova AN
    Arkh Anat Gistol Embriol; 1981 Jul; 81(7):72-8. PubMed ID: 6457590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral anticoagulants--the totem and the taboo.
    Breckenridge A
    Br Med J; 1976 Feb; 1(6007):419-23. PubMed ID: 766893
    [No Abstract]   [Full Text] [Related]  

  • 24. [Our experience in the anticoagulant treatment of myocardial infarct in patients of presenile and senile age].
    Molino N; Belluardo C
    Minerva Cardioangiol; 1967 Mar; 15(3):237-43. PubMed ID: 5604126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Administration of acetylsalicylic acid in patients under long-term oral anticoagulant therapy].
    Barth P; Walter E; Weber E
    Verh Dtsch Ges Inn Med; 1972; 78():723-6. PubMed ID: 4579268
    [No Abstract]   [Full Text] [Related]  

  • 26. [The relation between the physicochemical structure and the anticoagulant effects of polysulfated chitosan derivatives].
    Drozd NN; Sher AI; Makarov VA; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1994; 57(4):42-5. PubMed ID: 7950784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The action of cortisone on the function of the coagulant and anticoagulant systems of the blood].
    Seĭfulla RD
    Farmakol Toksikol; 1965; 28(3):333-6. PubMed ID: 5869651
    [No Abstract]   [Full Text] [Related]  

  • 28. Seasonal variations in blood clotting time in mice treated with an anticoagulant aminoestrogen.
    Rubio-Póo C; Silva G; Jaimez R; Lemini C
    Proc West Pharmacol Soc; 1998; 41():179-82. PubMed ID: 9836286
    [No Abstract]   [Full Text] [Related]  

  • 29. [Estimation of blood coagulation time by the coagulometer and quality control and evaluation of the test during anticoagulant administration].
    Matsuno M; Hashimoto T; Sakamoto M
    Rinsho Byori; 1971 Aug; 19():Suppl:62-3. PubMed ID: 5168180
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of the mutagenic effect of Redentin on various species of animals.
    Selypes A; Kékes-Szabó A; Nehéz M
    Acta Vet Hung; 1984; 32(3-4):213-7. PubMed ID: 6242282
    [No Abstract]   [Full Text] [Related]  

  • 31. [The pharmacological properties of a direct-action anticoagulant from the herb Nonea poulla (L.) D. C].
    Gubaev AG; Ortenberg EA; Rusakova OA; Chiriat'ev EA
    Eksp Klin Farmakol; 1996; 59(1):40-2. PubMed ID: 8704632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The blood coagulating system and the basis of anticoagulant therapy in frostbite of the extremities].
    Vikhriev BS; Skvortsov IuR; Kichemasov SKh; Zaĭtsev NA
    Probl Gematol Pereliv Krovi; 1982 Jun; 27(6):13-4. PubMed ID: 7111233
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of neocompensan (haemodesum) on the course of experimental myocardial infarct with arrhythmias in rabbits].
    Marshutina NV
    Farmakol Toksikol; 1978; 41(5):568-75. PubMed ID: 700080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complications of myocardial infarct in relation to the quality of anticoagulant stabilization].
    Schäbitz J; Vogel HC; Lukesch KH; Teichmann W; Kohlmann U
    Z Gesamte Inn Med; 1973 Oct; 28(19):Suppl:297-9. PubMed ID: 4766077
    [No Abstract]   [Full Text] [Related]  

  • 36. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The action on blood clotting of different lipoid fractions of beef brain. (Methods of fractionization and chromatographic isolation procedure of a phospholipid anticoagulant).
    Kahn MJ; Hans M; Bourgain RH
    Thromb Diath Haemorrh; 1965 Nov; 14(3-4):445-53. PubMed ID: 5893638
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologically active derivatives of geminally dialkylated indenes and indans. I. O-aminoalkyl ethers of 3,3-dialkyl-1-hydroxyimmunoindans.
    Jönsson NA; Merényi F; Dahlander B
    Acta Pharm Suec; 1978; 15(6):406-18. PubMed ID: 749545
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental studies on hyperbaric oxygenation.
    Ciocatto E; Moricca G; Querci M; Cabrai M
    Panminerva Med; 1965 Nov; 7(11):419-24. PubMed ID: 5858654
    [No Abstract]   [Full Text] [Related]  

  • 40. N-aminoalkylsuccinimides as local anaesthetics. III. 1,2,3,4-Tetrahydronaphthalene-2-, indane-1-, and indane-2-spiro-3'-pyrrolidine-2'-5'-diones.
    Sandberg R; Domeij KE; Stening G; Willman N; Akerman B
    Acta Pharm Suec; 1980; 17(4):177-82. PubMed ID: 7468237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.